A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
Clinical trial NCT00006509 · COMPLETED
Trial details
- NCT number
- NCT00006509
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.